One-Day Agenda
Sessions
Partner Slots
Breaks & Admin
AM Insights
Pharma Supply Chains 2027 – Global Trends, Risks and Market Outlook
- Examining global pharma supply-chain trends, market shifts, and evolving demand patterns
- Addressing geopolitical risks, shortages, disruptions, and cost pressures shaping 2027
Presentation 1
Procurement & Strategic Sourcing: Managing Suppliers, Costs and Availability
- Strengthening supplier sourcing, qualification, diversification, and strategic partnerships
- Controlling procurement costs while ensuring reliable supply and product availability
TBC
Presentation 2
Forecasting the Unforecastable: How Should Pharma Plan for Demand Volatility?
- Managing launches, shortages, seasonal demand, market changes, biosimilars and unpredictable patient demand
- Moving from static forecasts and spreadsheets toward continuous planning, scenario modelling and AI-assisted forecasting
TBC
Panel Discussion
Can Pharma & Biotech Build Supply Chains That Are Truly Resilient?
- Balancing resilience, inventory costs, supplier diversification, and operational efficiency
- Preparing for shortages, geopolitical disruptions, capacity constraints, and transportation risks
- Building agile supply networks through regionalization, digital visibility, and contingency planning
TBC
Presentation 3
Supplier Risk Management & Qualification: Building a Reliable Supply Base
- Identifying supplier risks through robust qualification, audits, performance monitoring, and risk assessments
- Building a resilient supplier base through diversification, contingency planning, and strategic partnerships
Presentation 4
Inventory Optimization: Balancing Service Levels, Working Capital and Supply Security
- Optimizing inventory levels to maintain service levels while reducing excess stock and working capital
- Strengthening supply security through safety-stock strategies, demand forecasting, and scenario planning
Spotlight Presentation
From Supplier to Patient: Building True End-to-End Visibility
- Connecting suppliers, manufacturers, logistics and distributors
- Control towers, track-and-trace and real-time data
Afternoon exchange
DSCSA, Serialization & End-to-End Pharmaceutical Traceability: What Comes Next?
- Advancing DSCSA compliance through serialization, data interoperability, and trading-partner connectivity
- Enhancing end-to-end traceability to strengthen product security, recall readiness, and supply-chain visibility
Presentation 5
San Diego–Tijuana & Cross-Border Life Sciences Supply Chains: Opportunities, Risks & the Road Ahead
- Exploring nearshoring opportunities and integrated pharma manufacturing across the San Diego–Tijuana region
- Addressing customs, regulatory, transportation, security, and cross-border supply risks
TBC
Panel Discussion
The Pharma Supply Chain of 2030: What Will Change, What Will Stay & What Must Start Now?
- How AI, automation, and digitalization will reshape pharma supply-chain operations
- Balancing resilience, regionalization, sustainability, cost, and patient-centric supply models
- Preparing today for future disruptions, advanced therapies, and evolving regulatory requirements